Identification and characterization of pyrrolidine diastereoisomers as potent functional agonists and antagonists of the human melanocortin-4 receptor
- PMID: 18032040
- DOI: 10.1016/j.bmcl.2007.10.115
Identification and characterization of pyrrolidine diastereoisomers as potent functional agonists and antagonists of the human melanocortin-4 receptor
Abstract
A series of trans-4-phenylpyrrolidine-3-carboxamides were synthesized and characterized as potent ligands of the human melanocortin-4 receptor. Interestingly, a pair of diastereoisomers 13b displayed potent functional agonist and antagonist activity, respectively. Thus, the 3S,4R-pyrrolidine 13b-1 possessed a Ki of 1.0 nM and an EC50 of 3.8 nM, while its 3R,4S-isomer 13b-2 exhibited a Ki of 4.7 and an IC50 of 64 nM. Both compounds were highly selective over other melanocortin receptor subtypes. The MC4R agonist 13b-1 also demonstrated efficacy in a diet-induced obesity model in rats.
Similar articles
-
Synthesis and characterization of pyrrolidine derivatives as potent agonists of the human melanocortin-4 receptor.Bioorg Med Chem Lett. 2007 Dec 1;17(23):6546-52. doi: 10.1016/j.bmcl.2007.09.079. Epub 2007 Oct 22. Bioorg Med Chem Lett. 2007. PMID: 17933528
-
Synthesis and characterization of trans-4-(4-chlorophenyl)pyrrolidine-3-carboxamides of piperazinecyclohexanes as ligands for the melanocortin-4 receptor.Bioorg Med Chem Lett. 2007 Dec 15;17(24):6825-31. doi: 10.1016/j.bmcl.2007.10.032. Epub 2007 Oct 17. Bioorg Med Chem Lett. 2007. PMID: 17964151
-
Design and synthesis of 3-arylpyrrolidine-2-carboxamide derivatives as melanocortin-4 receptor ligands.Bioorg Med Chem Lett. 2008 Mar 15;18(6):1931-8. doi: 10.1016/j.bmcl.2008.01.125. Epub 2008 Feb 7. Bioorg Med Chem Lett. 2008. PMID: 18294847
-
Melanocortin-4 receptor agonists for the treatment of obesity.Curr Opin Investig Drugs. 2004 Oct;5(10):1063-71. Curr Opin Investig Drugs. 2004. PMID: 15535427 Review.
-
Melanocortin-4 receptor (MC4R) agonists for the treatment of obesity.J Med Chem. 2006 Jul 13;49(14):4035-43. doi: 10.1021/jm058241a. J Med Chem. 2006. PMID: 16821763 Review. No abstract available.
Cited by
-
The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options.Int J Obes (Lond). 2014 Feb;38(2):163-9. doi: 10.1038/ijo.2013.80. Epub 2013 Jun 18. Int J Obes (Lond). 2014. PMID: 23774329
-
Current Mechanistic and Pharmacodynamic Understanding of Melanocortin-4 Receptor Activation.Molecules. 2019 May 16;24(10):1892. doi: 10.3390/molecules24101892. Molecules. 2019. PMID: 31100979 Free PMC article. Review.
-
Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016.Biochim Biophys Acta Mol Basis Dis. 2017 Oct;1863(10 Pt A):2414-2435. doi: 10.1016/j.bbadis.2017.03.020. Epub 2017 Mar 29. Biochim Biophys Acta Mol Basis Dis. 2017. PMID: 28363699 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information